Want to see HK:0809 full AI Analyst Report?
Top Page
Global Bio-chem Technology Group Co. Ltd.
(0809)
Select Model
Select Model
Rating:43Neutral
Price Target:
HK$0.36
â–²(503.33% Upside)
Action:Reiterated
Date:09/26/26
The score is held down primarily by weak financial performance—especially persistent negative equity, elevated leverage, negative EBIT, and recently negative operating/free cash flow. Technicals are also soft with the stock trading below key longer-term moving averages and negative MACD. A very low P/E provides some valuation support, but it is outweighed by the financial risk signals.
Positive Factors
Diversified End-Market Exposure
Serving food, beverage, pharmaceutical, and industrial customers gives the company exposure to multiple demand pools. This breadth can reduce reliance on one end market and supports a durable platform for selling corn-derived ingredients across applications over the next several quarters.
Negative Factors
Negative Equity and High Leverage
Persistent negative shareholders’ equity and large debt indicate structural balance-sheet weakness rather than a temporary setback. This reduces resilience, makes leverage metrics unfavorable, limits access to financial flexibility and leaves the company more exposed to refinancing pressure.
Read all positive and negative factors
Positive Factors
Negative Factors
Diversified End-Market Exposure
Serving food, beverage, pharmaceutical, and industrial customers gives the company exposure to multiple demand pools. This breadth can reduce reliance on one end market and supports a durable platform for selling corn-derived ingredients across applications over the next several quarters.
Read all positive factors
Global Bio-chem Technology Group Co. Ltd. (0809) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$614.52M
Dividend Yield2.57%
Average Volume (3M)562.54K
Price to Earnings (P/E)1.9
Beta (1Y)0.08
Revenue Growth-8.40%
EPS Growth-77.49%
CountryHK
Employees1,890
SectorConsumer Defensive
Sector Strength42
IndustryAgricultural - Commodities/Milling
Share Statistics
EPS (TTM)0.20
Shares Outstanding1,683,277,100
10 Day Avg. Volume460,580
30 Day Avg. Volume562,541
Financial Highlights & Ratios
PEG Ratio-0.06
Price to Book (P/B)-1.36
Price to Sales (P/S)0.31
P/FCF Ratio-24.77
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Global Bio-chem Technology Group Co. Ltd. Business Overview & Revenue Model
Company Description
Global Bio-chem Technology Group Company Limited, an investment holding company, manufactures and sells corn refined products and corn-based biochemical products in the People's Republic of China, Asia, the Americas, and internationally. It operat...
How the Company Makes Money
The company primarily makes money by manufacturing and selling corn-based biochemical products. Key revenue streams typically include: (1) sales of starch and modified starch products used as functional ingredients (e.g., thickeners, binders) in f...
Global Bio-chem Technology Group Co. Ltd. Financial Statement Overview
Summary
Income Statement
34
Negative
Balance Sheet
12
Very Negative
Cash Flow
23
Negative
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.10B | 2.28B | 2.00B | 1.37B | 12.71M | 746.55M |
| Gross Profit | 38.16M | 196.44M | 218.68M | 43.64M | -263.37M | 48.35M |
| EBITDA | -155.45M | 578.15M | 16.85M | 4.69B | -469.06M | 785.63M |
| Net Income | 104.17M | 156.30M | 769.60M | 4.22B | -1.44B | -400.80M |
Balance Sheet | ||||||
| Total Assets | 4.88B | 4.62B | 4.54B | 5.21B | 5.85B | 6.48B |
| Cash, Cash Equivalents and Short-Term Investments | 126.34M | 94.44M | 85.47M | 315.41M | 41.77M | 109.13M |
| Total Debt | 1.86B | 1.79B | 3.69B | 5.45B | 8.91B | 8.44B |
| Total Liabilities | 5.69B | 5.14B | 6.50B | 9.25B | 13.64B | 13.18B |
| Stockholders Equity | -814.22M | -518.52M | -1.95B | -4.04B | -7.54B | -6.52B |
Cash Flow | ||||||
| Free Cash Flow | -79.30M | -28.39M | 76.04M | -94.24M | -94.19M | -501.02M |
| Operating Cash Flow | -61.46M | -7.35M | 76.04M | -50.46M | -88.01M | -475.21M |
| Investing Cash Flow | -17.84M | -21.04M | -535.00K | -14.37M | -413.00K | 392.59M |
| Financing Cash Flow | 10.75M | 33.57M | -76.06M | 112.62M | 109.75M | -48.66M |
Global Bio-chem Technology Group Co. Ltd. Technical Analysis
Neutral
0.06
Price Trends
0.39
Negative
0.45
Negative
0.54
Negative
Market Momentum
>-0.01
Negative
49.06
Neutral
21.21
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0809, the sentiment is Neutral. The current price of 0.06 is below the 20-day moving average (MA) of 0.38, below the 50-day MA of 0.39, and below the 200-day MA of 0.54, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 49.06 is Neutral, neither overbought nor oversold. The STOCH value of 21.21 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for HK:0809.
Global Bio-chem Technology Group Co. Ltd. Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | HK$3.06B | 8.28 | 18.48% | 4.93% | 33.56% | 59.06% | |
73 Outperform | HK$1.20B | 8.34 | 6.00% | 10.46% | 4.72% | 20.03% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
54 Neutral | HK$98.23M | -38.18 | -0.49% | 5.24% | 30.41% | 98.08% | |
51 Neutral | HK$160.30M | -1.07 | 38.51% | 0.84% | -7.04% | 8.69% | |
47 Neutral | HK$1.05B | 49.94 | 0.45% | 5.41% | -5.24% | -95.65% | |
43 Neutral | HK$614.52M | 1.88 | -15.63% | 2.57% | -8.40% | -77.49% |
* Consumer Defensive Sector Average
HK:0809
Global Bio-chem Technology Group Co. Ltd.
0.38
-0.62
-62.12%
HK:3889
Global Sweeteners Holdings Limited
0.08
-0.01
-11.70%
HK:1837
Natural Food International Holding Ltd.
1.40
0.50
56.42%
HK:2317
Vedan International (Holdings) Ltd.
0.79
0.20
34.65%
HK:3838
China Starch Holdings Limited
0.18
>-0.01
-2.69%
HK:0841
Asia Cassava Resources Holdings Limited
0.17
0.05
44.83%
Global Bio-chem Technology Group Co. Ltd. Corporate Events
Global Bio-chem launches upgraded boilers and coenzyme Q10 expansion in Jilin
Sep 2, 2026
Global Bio-chem Technology Group has completed a flagship boiler refurbishment project at its Dehui production site in Jilin Province and officially commissioned upgraded high-temperature and ultra-high-pressure boilers. The initiative is designed...
Global Bio-chem interim loss widens as margins collapse
Aug 28, 2026
Global Bio-chem Technology reported unaudited interim results for the six months ended 30 June 2026 showing a sharp deterioration in profitability despite only a moderate decline in revenue. Revenue fell to HK$1.00 billion from HK$1.19 billion yea...
Global Bio-chem announces sweeping board and management reshuffle
Aug 19, 2026
Global Bio-chem Technology Group Company Limited has announced a broad reshuffle of its top leadership and governance roles, including changes to the board, board committees, and senior management. The move realigns key positions such as chairman,...
Global Bio-chem Sets Out Board and Committee Structure
Aug 19, 2026
Global Bio-chem Technology Group Co. Ltd. has announced the current composition of its board of directors, comprising executive, non-executive and independent non-executive members. The board structure reflects a mix of management and external ove...
Global Bio-chem Sets Board Meeting to Review Interim Results and Possible Dividend
Aug 18, 2026
Global Bio-chem Technology Group Company Limited has scheduled a board meeting for 28 August 2026 to review the unaudited interim results for the six months ended 30 June 2026. The board will also consider the potential declaration of an interim d...
Global Bio-chem Signs RMB1.5 Billion Counter-Guarantee Deal With Major Shareholder Nongfa
Jul 27, 2026
Global Bio-chem Technology Group Co. Ltd. has entered into a three-year counter-guarantee agreement with major shareholder Nongfa, under which the company will provide counter-guarantees backing Nongfa’s guarantees to financial institutions ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.